MicroRNA-761 is downregulated in colorectal cancer and regulates tumor progression by targeting Rab3D

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a major global health concern.
• Dysregulation of microRNAs is implicated in cancer development and progression.
• The specific role of microRNA-761 (miR-761) in CRC remains largely unexplored.

Purpose of the Study:

• To elucidate the biological function of miR-761 in colorectal cancer.
• To identify the molecular mechanisms underlying miR-761's regulation of CRC cell proliferation and migration.
• To investigate potential therapeutic targets associated with miR-761 in CRC.

Main Methods:

• Quantitative polymerase chain reaction (qPCR) to assess miR-761 expression levels in CRC tissues and cell lines.
• In vitro assays to evaluate the effects of miR-761 overexpression on CRC cell proliferation and migration.
• Bioinformatics analysis and luciferase reporter assays to identify and validate direct targets of miR-761.
• Western blot analysis to confirm protein expression levels of identified targets.

Main Results:

• miR-761 expression was significantly downregulated in colorectal cancer tissues and cell lines compared to normal controls.
• Overexpression of miR-761 markedly suppressed CRC cell proliferation and migration.
• Rab3D was identified as a direct downstream target of miR-761, with inverse correlation in expression.
• Restoration of Rab3D expression attenuated the inhibitory effects of miR-761 on CRC cell behavior.

Conclusions:

• miR-761 functions as a tumor suppressor in colorectal cancer.
• miR-761 inhibits CRC cell proliferation and migration, at least partly, through direct targeting of Rab3D.
• These findings highlight miR-761 as a potential therapeutic agent for colorectal cancer treatment.